SCHEMBL20174634

SCHEMBL20174634

c1ccc(-c2cc(-c3ccc(-c4ccc5c(c4)-c4c(sc6ccccc46)C54c5ccccc5-c5ccccc54)cc3)cc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
PDK2 Q15119 2/20 0.33
CTRC Q99895 1/20 0.33
PIM1 P11309 1/20 0.32
S1PR5 Q9H228 5/20 0.32
S1PR4 O95977 4/20 0.32
CYP1A2 P05177 2/20 0.31
ADORA2A P29274 1/20 0.30
ADORA2B P29275 1/20 0.30
ADORA1 P30542 1/20 0.30
ALDH1A1 P00352 2/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
CYP2C19 P33261 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
AR P10275 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174609 0.93 PDK2 (0.34) PDK2KDM4EMAPT
SCHEMBL20174630 0.92 CYP1A1 (0.37) CYP1A1CYP1B1PDK2CTRCPIM1
SCHEMBL20174647 0.89 PDK2 (0.40) PDK2
SCHEMBL20174593 0.89 PDK2 (0.40) PDK2
SCHEMBL20174601 0.89 PDK2 (0.40) PDK2
SCHEMBL20174626 0.88 CYP1A1 (0.39) CYP1A1CYP1B1PDK2CTRCPIM1
SCHEMBL20174589 0.88 MEN1 (0.32) PDK2
SCHEMBL20174735 0.88 CYP1A1 (0.39) CYP1A1CYP1B1PDK2CTRCPIM1
SCHEMBL20174570 0.88 ALOX5 (0.32) PDK2KDM4EMAPT
SCHEMBL20174680 0.87 ACACA (0.37) CYP1A1CYP1B1PIM1S1PR5S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG CYP1A1 726/4885CYP1B1 725/4885PDK2 651/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG CYP1A1 726/4885CYP1B1 725/4885PDK2 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.